Further studies also revealed that YY1 represses the TRAIL receptor DR5 and its inhibition by NO or by the upregulation of RKIP resulted in the sensitization of TRAIL-resistant tumor cells to TRAIL apoptosis [83, 84]. Here, YY1 is linked to neoplasm.